Thermo Fisher boosts sequencing business with $13.6B Life Tech buy

Thermo Fisher Scientific agreed to acquire Life Technologies, a maker of laboratory equipment for the life sciences, for $13.6 billion. The acquisition, which is expected to be finalized early next year, would make Thermo Fisher a major player in the next-generation gene sequencing market. The deal also improves "all three elements of our growth strategy: technological innovation, a unique customer value proposition, and expansion in emerging markets," Thermo Fisher President and CEO Marc Casper said.

View Full Article in:

GenomeWeb Daily News (free registration) · American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN